FIIs Sell Rs 583 Cr While Pharma Mutual Funds Surge 28%
By Market Desk
Foreign investors net sold Rs 583 crore in Indian equities while domestic buying supported the market. Pharma mutual funds surge over 28% annually.
Institutional Trading Dynamics
The Indian equity market witnessed a divergence in institutional activity on September 9, 2026. Foreign Institutional Investors (FIIs) acted as net sellers during the session, offloading stocks valued at Rs 583 crore.
Conversely, Domestic Institutional Investors (DIIs) provided support to the broader market by emerging as net buyers. Their total purchases for the day amounted to Rs 1,509 crore.
Pharmaceutical Sector Performance
Beyond institutional flows, the pharmaceutical mutual fund segment has exhibited significant upward momentum over the past year. Investors focused on the healthcare space have seen robust returns, particularly among leading fund houses.
Key performance highlights include:
Kotak Healthcare Fund has emerged as the frontrunner within the category, delivering returns exceeding 28% over the past 12-month period.
The sector’s growth trajectory is reflected in the relative performance of various specialized schemes. Comparative analysis indicates that funds such as the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund are among the prominent participants navigating the current market environment.
The sustained momentum in pharmaceutical funds highlights investor confidence in the sector’s growth prospects. As market participants evaluate these performance metrics, the relative strength of individual fund houses remains a critical factor for ongoing portfolio allocations in the pharmaceutical space.